Crawford Fund Management, LLC Cure Vac N.V. Put Options Transaction History

Crawford Fund Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$2.74 - $3.79 $105,490 - $145,915	-38,500 Reduced 62.1%	23,500 $69.1 Million
Q2 2024 Aug 14, 2024	SELL	$2.31 - $4.99 $19,635 - $42,415	-8,500 Reduced 12.06%	62,000 $211 Million
Q1 2024 May 15, 2024	SELL	$2.94 - $4.34 $176,106 - $259,966	-59,900 Reduced 45.94%	70,500 $214 Million
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $516,384 - $835,864	130,400 New	130,400 $549 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Fund Management, LLC with notifications on news.